| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 |
Revenue  | 299 | 283 | 270 | 285 | 353 | 363 | 352 | 371 | 336 | 390 | 375 | 328 | 471 | 428 | 355 | 351 | 514 | 458 | 428 | 442 | 566 | 514 | 483 | 482 | 667 | 549 | 483 | 508 |
| Expenses | 218 | 216 | 200 | 229 | 265 | 272 | 237 | 304 | 205 | 266 | 267 | 264 | 332 | 326 | 294 | 322 | 417 | 378 | 360 | 386 | 414 | 410 | 374 | 406 | 492 | 444 | 418 | 438 |
| EBITDA | 81 | 66 | 71 | 56 | 88 | 91 | 116 | 67 | 132 | 125 | 109 | 65 | 139 | 102 | 61 | 29 | 97 | 80 | 68 | 56 | 151 | 104 | 109 | 77 | 175 | 105 | 66 | 70 |
| Operating Profit % | 25 % | 21 % | 22 % | 15 % | 23 % | 21 % | 26 % | 9 % | 34 % | 28 % | 22 % | 16 % | 26 % | 18 % | 14 % | 6 % | 16 % | 15 % | 12 % | 11 % | 23 % | 16 % | 18 % | 12 % | 23 % | 14 % | 10 % | 11 % |
| Depreciation | 9 | 9 | 8 | 8 | 9 | 10 | 9 | 9 | 9 | 10 | 9 | 10 | 10 | 10 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 14 | 13 | 16 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 72 | 57 | 63 | 48 | 78 | 80 | 106 | 57 | 121 | 114 | 99 | 54 | 128 | 91 | 51 | 19 | 87 | 69 | 57 | 45 | 141 | 93 | 98 | 65 | 163 | 90 | 51 | 53 |
| Tax | 23 | 16 | 17 | 13 | 22 | 26 | 32 | 1 | 30 | 26 | 24 | 7 | 31 | 19 | 15 | 9 | 16 | 17 | 16 | 15 | 31 | 23 | 18 | 19 | 44 | 18 | 14 | 15 |
| Net Profit | 49 | 40 | 46 | 35 | 56 | 54 | 74 | 56 | 92 | 88 | 75 | 47 | 98 | 72 | 36 | 10 | 71 | 52 | 41 | 31 | 110 | 70 | 79 | 46 | 119 | 72 | 37 | 39 |
| EPS in ₹ | 2.80 | 2.31 | 2.62 | 2.00 | 3.22 | 3.14 | 4.31 | 3.22 | 5.36 | 5.15 | 4.45 | 2.77 | 5.80 | 4.28 | 2.11 | 0.62 | 4.23 | 3.10 | 2.45 | 1.85 | 6.62 | 4.22 | 4.86 | 2.84 | 7.31 | 4.43 | 2.28 | 2.38 |
FDC
FDC
487.15
-2.05
(-0.42%)
Market Cap
7,931.29 Cr
EPS
16.39
PE Ratio
29.82
Dividend Yield
2.05 %
Industry
Healthcare52 Week High
658.85
52 Week Low
366.25
PB Ratio
3.49
Debt to Equity
0.01
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,702.20 | #1 4,08,414.80 | 35.57 | #1 54,729.00 | 12.06 | #1 10,980 | -18.99 | 55.97 | |
6,584.00 | 1,74,784.51 | 80.22 | 9,712.00 | 0.89 | 2,191 | 23.05 | 40.37 | |
1,572.00 | 1,26,971.67 | 22.93 | 28,409.50 | 7.12 | 5,291 | 9.88 | 70.77 | |
3,622.90 | 1,21,969.00 | 63.65 | 11,539.40 | 6.99 | 1,911 | 19.91 | 72.46 | |
1,287.40 | 1,07,442.68 | #1 18.77 | 33,741.20 | 16.73 | 5,725 | 1.26 | 54.50 | |
2,541.60 | 1,04,899.14 | 61.83 | 12,744.20 | 19.57 | 2,007 | -10.91 | 52.39 | |
980.10 | 98,620.99 | 21.15 | 23,511.00 | 13.82 | 4,615 | -0.19 | 54.96 | |
1,960.50 | 89,535.15 | 27.44 | 22,909.50 | #1 19.94 | 3,306 | #1 112.49 | 53.75 | |
32,895.00 | 69,899.58 | 50.72 | 6,684.70 | 10.80 | 1,414 | 27.83 | 42.22 | |
1,127.00 | 65,456.34 | 18.86 | 31,378.10 | 17.55 | 3,366 | -0.50 | 47.15 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
11.51 %
Net Income Growth
57.43 %
Cash Flow Change
42.52 %
ROE
48.77 %
ROCE
43.91 %
EBITDA Margin (Avg.)
31.20 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 1,149 | 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 |
| Fixed Assets | 393 | 675 | 678 | 674 | 682 | 674 | 689 | 705 | 699 | 680 | 988 |
| Current Assets | 502 | 523 | 708 | 722 | 740 | 927 | 934 | 1,000 | 1,027 | 1,067 | 1,089 |
| Capital Work in Progress | 29 | 20 | 6 | 13 | 12 | 24 | 19 | 105 | 198 | 262 | 136 |
| Investments | 273 | 325 | 491 | 471 | 585 | 665 | 790 | 886 | 806 | 843 | 375 |
| Other Assets | 454 | 246 | 293 | 348 | 360 | 451 | 458 | 575 | 640 | 684 | 0 |
| Total Liabilities | 1,149 | 1,266 | 1,468 | 1,505 | 1,640 | 1,813 | 1,956 | 2,270 | 2,343 | 2,468 | 2,714 |
| Current Liabilities | 188 | 163 | 179 | 212 | 179 | 246 | 204 | 272 | 312 | 311 | 362 |
| Non Current Liabilities | 24 | 20 | 18 | 18 | 16 | 19 | 19 | 42 | 50 | 60 | 71 |
| Total Equity | 936 | 1,083 | 1,270 | 1,276 | 1,445 | 1,547 | 1,734 | 1,956 | 1,981 | 2,097 | 2,281 |
| Reserve & Surplus | 919 | 1,065 | 1,252 | 1,259 | 1,428 | 1,530 | 1,717 | 1,940 | 1,966 | 2,081 | 2,265 |
| Share Capital | 18 | 18 | 18 | 18 | 18 | 17 | 17 | 17 | 17 | 16 | 16 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -9 | 4 | 11 | 1 | -8 | 10 | 1 | 7 | -14 | 2 |
| Investing Activities | -89 | -73 | -144 | 21 | -121 | -98 | -77 | -145 | 11 | -17 |
| Operating Activities | 128 | 174 | 155 | 150 | 112 | 250 | 207 | 162 | 155 | 221 |
| Financing Activities | -48 | -97 | 0 | -169 | -0 | -142 | -129 | -10 | -180 | -202 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 69.35 % | 69.35 % | 69.35 % | 69.36 % | 69.36 % | 69.50 % | 69.50 % | 69.50 % | 69.50 % | 69.50 % | 69.66 % | 69.66 % | 69.66 % | 69.66 % | 69.66 % | 69.66 % | 69.66 % | 69.66 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 2.65 % | 2.51 % | 2.62 % | 2.67 % | 2.55 % | 2.41 % |
| DIIs | 3.98 % | 4.28 % | 4.57 % | 5.37 % | 5.81 % | 6.00 % | 6.72 % | 7.76 % | 8.27 % | 8.95 % | 8.00 % | 7.61 % | 6.94 % | 6.73 % | 6.03 % | 6.08 % | 6.37 % | 7.17 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 16.15 % | 16.82 % | 16.79 % | 16.61 % | 16.32 % | 16.35 % | 16.05 % | 15.42 % | 14.93 % | 15.59 % | 15.94 % | 16.12 % | 16.54 % | 16.71 % | 16.70 % | 16.57 % | 16.22 % | 16.17 % |
| Others | 10.52 % | 9.55 % | 9.29 % | 8.67 % | 8.51 % | 8.15 % | 7.73 % | 7.32 % | 7.31 % | 5.96 % | 6.40 % | 6.61 % | 4.22 % | 4.39 % | 5.00 % | 5.02 % | 5.20 % | 4.59 % |
| No of Share Holders | 0 | 40,327 | 49,335 | 49,889 | 53,582 | 86,503 | 65,318 | 63,172 | 57,012 | 56,717 | 56,928 | 55,341 | 52,377 | 50,634 | 55,400 | 55,228 | 53,880 | 54,445 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 2.25 | 0.00 | 0.00 | 0.8 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.9 | 0.00 | 0.00 | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 May 2025 |  Quarterly Result Announcement | NA | 28 May 2025 | 467.35 | 459.50 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 478.35 | 461.60 |
| 22 Nov 2024 |  Dividend | ₹ 5.00 /share | 22 Nov 2024 | 541.05 | 485.50 |
| 06 Nov 2024 | Quarterly Result Announcement | NA | 06 Nov 2024 | 516.70 | 541.05 |
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 560.65 | 559.40 |
| 27 Sept 2023 | Annual General Meeting | NA | 27 Sept 2023 | 377.90 | 374.70 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jul 08, 2025
Jul 08, 2025Closure of Trading WindowJun 27, 2025
Jun 27, 2025Clarification On Spurt In VolumeJun 17, 2025
Jun 17, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
May 29, 2025Results-Financial Results For March 312025May 28, 2025
May 28, 2025Board Meeting Outcome for Outcome For The Board Meeting Held On May 282025May 28, 2025
May 28, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 26, 2025
May 26, 2025Board Meeting Intimation for Audited Standalone & Consolidated Financial Results Of The Company For The Quarter And Year Ended March 312025.May 22, 2025
May 22, 2025Announcement Under Regulation 30 (LODR) - Expansion Of Liquid Oral Facility At CompanyS Sinnar PlantApr 30, 2025
Apr 30, 2025Confirmation Regarding Company Not Falling Under Large Corporate Criteria As On March 31 2025Apr 24, 2025
Apr 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Apr 14, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 19, 2025
Feb 19, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Feb 12, 2025Unaudited Financial Results For Quarter And Nine Months Ended 31St December 2024Feb 12, 2025
Feb 12, 2025Board Meeting Outcome for Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter And Nine Months Ended 31St December2024Feb 12, 2025
Feb 12, 2025Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024.Feb 07, 2025
Feb 07, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015Jan 31, 2025
Jan 31, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Jan 10, 2025 Intimation Of Change In Name Of CompanyS Registrar And Share Transfer Agent (RTA)Jan 02, 2025
Jan 02, 2025Intimation Regarding Approval Received From US FDA For ANDA- Cefixime 400 Mg TabletsDec 18, 2024
Dec 18, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 13, 2024
Dec 13, 2024Announcement Under Regulation 30 (LODR) - Intimation Of Company''s New Correspondence AddressDec 12, 2024
Dec 12, 2024Receipt Of Establishment Inspection Report (EIR) From US FDA With No Observations (Zero 483 S), As Closure Of Inspection Conducted At Company''s Manufacturing Facility Located At Baddi, Himachal Pradesh.Nov 13, 2024
Nov 13, 2024Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 07, 2024
Nov 07, 2024Corporate Action-Fixation Of Record Date For 1St Interim Dividend For FY 24-25.Nov 06, 2024
Nov 06, 2024Corporate Action-Board approves DividendNov 06, 2024
Nov 06, 2024Unaudited ( Standalone And Consolidated) Financial Results For Quarter And Half Year Ended On September 30,2024.Nov 06, 2024
Nov 06, 2024Board Meeting Outcome for Outcome Of Board Meeting For Approving Unaudited Financial Results For Quarter And Half Year Ended 3Oth September 2024Nov 06, 2024
Nov 06, 2024Board Meeting Intimation for Board Meeting Scheduled To Be Held On November 06,2024.Oct 28, 2024
Oct 28, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Oct 07, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 04, 2024
Oct 04, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 27, 2024
Sep 27, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Sep 27, 2024Closure of Trading WindowSep 26, 2024
Sep 26, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Sep 26, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 24, 2024
Sep 24, 2024Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Sep 11, 2024
Sep 11, 2024Update W.R.T. Composition Of Board Committees Of FDC Limited.Sep 06, 2024
Sep 06, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateSep 06, 2024
Sep 06, 2024Announcement under Regulation 30 (LODR)-Change in DirectorateSep 06, 2024
Sep 06, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Sep 04, 2024Business Responsibility and Sustainability Reporting (BRSR)Sep 03, 2024
Sep 03, 2024Notice Of The 84Th Annual General Meeting (AGM) Of FDC LimitedSep 03, 2024
Sep 03, 2024Reg. 34 (1) Annual Report.Sep 03, 2024
Sep 03, 2024Intimation Of Book Closure And Cut-Off Date In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirement) Regulation 2015Sep 02, 2024
Sep 02, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 27, 2024
Aug 27, 2024US-FDA Inspection At Company''s Manufacturing Facility Located At Baddi, Himachal PradeshAug 23, 2024
Aug 23, 2024Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Aug 08, 2024
Aug 08, 2024Technical Indicators
RSI(14)
Neutral 52.55
ATR(14)
Less Volatile 13.08
STOCH(9,6)
Neutral 27.22
STOCH RSI(14)
Oversold 6.11
MACD(12,26)
Bearish -2.78
ADX(14)
Strong Trend 28.18
UO(9)
Bearish 53.71
ROC(12)
Downtrend But Slowing Down -3.19
WillR(14)
Neutral -73.51
Mutual Fund Holdings
ICICI Prudential Multicap Fund Direct Plan-Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
ITI Pharma and Healthcare Fund Direct - Growth 
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth 
Nippon India Small Cap Fund Direct- Growth 
HDFC BSE 500 Index Fund Direct - Growth 
Bandhan BSE Healthcare Index Fund Direct-Growth 
Angel One Nifty Total Market Index Fund Direct - Growth 
Groww Nifty Total Market Index Fund Direct - Growth 
Mirae Asset Nifty Total Market Index Fund Direct-Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth 
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
